NCT02405858 2025-02-03A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade TherapyJanssen Pharmaceutical K.K.Phase 4 Completed51 enrolled